network is more difficult to reconcile with the effects of inhibitory GABA signalling. Fidelin et al. [7] envisage that postinhibitory rebound might underpin this effect. This phenomenon, which causes membrane depolarisation following a period of inhibition, is known to trigger spike activity in neurons within CPGs of other species [10] [11] [12] and it is certainly possible that a build-up of GABAergic inhibition is sufficient to trigger postinhibitory rebound in zebrafish neurons that drive slow swimming.
Other possibilities merit consideration, however. For example, in some cells GABA has complex effects, depolarising cells at rest but shunting the membrane and depressing firing when cells are excited [13, 14] . Such a phenomenon could underpin GABAs context-dependent effects on the spinal network. Alternatively, the excitatory actions of CSF-cNs could arise from metabotropic GABA B receptor activation or co-release of neuropeptides that are known to be expressed by these cells [6] . One other possibility is that CSF-cNs may also synapse with other spinal neurons which may exert opposing influences over CPG activity.
Another outstanding issue is that the physiological stimuli responsible for driving CSF-cN activity remain unknown. The experiments detailed in the current study relied on optogenetic methods to artificially stimulate CSF-cNs so we still know little about the natural physiological conditions that lead to their activation. With their ciliated CSF-contacting projections, these cells are uniquely positioned to modify CPG parameters in response to changes in CSF composition or flow. With the powerful suite of optogenetic, physiological, imaging and behavioural methods now available to zebrafish researchers, a holistic understanding of this intriguing cell class is well within reach. 4 A new study shows that subjects rendered unresponsive with sedatives do not exhibit a stereotypic 'unconscious' response to direct cortical stimulation; instead, agent-specific effects are seen that can distinguish between unresponsiveness with and without consciousness.
How a brain generates consciousness remains one of the most interesting mysteries in biology, and is of paramount importance to philosophy, neuroscience and medicine. In the last decade several discoveries have been made about operating principles that a nervous system must display in order to exhibit conscious behavior. Two main features of a conscious brain are described as 'integration' and 'differentiation' by Sarasso et al. [1] in a study reported in this issue of Current Biology. During consciousness, integration is seen as complex activity patterns that are distributed across interacting cortical regions. Differentiation in time and space across these cortical areas is indicative of an ability to carry higher levels of information. The group that led the new study has developed a perturbational complexity index (PCI) that provides a measure of both integration and differentiation for cortical field potential responses to transcranial magnetic stimulation (TMS) of a small volume of cortex [2] . In healthy subjects, PCI values range from highs of 0.4 to 0.7 while awake, to low values (0.2 to 0.3) during slow-wave sleep, when subjects are unconscious, and then back to higher levels (0.35 to 4.5) during the paradoxical consciousness of dreaming during REM sleep [2] .
Measuring Consciousness
There is a growing need to have a quantitative assessment of consciousness, and the PCI may be the best measure currently available [3] . In neurology, such a measure is needed to assess the degree of brain function in comatose patients. In psychiatry it could help with diagnoses and tracking treatment results for sleep disorders, 'locked-in' syndrome, and other forms of vegetative states. A measure of conscious awareness during anesthesia is needed as outcomes analysis has clearly shown that lighter anesthesia is associated with reduced risk for morbidity and mortality following surgery. But no one wants their patient so lightly anesthetized that they experience or remember their surgery. As head injury continues to increase from auto accidents, sports injuries and war, it is important we develop better tools to assess effects of such injuries on conscious brain function.
Consciousness in an Unresponsive Brain
As a further test of PCI's ability to measure consciousness, Sarasso et al. tested whether it can distinguish between anesthetics that suppress dream-like activity (propofol and xenon) vs ketamine, an agent that has long been associated with emergence dreams and an awake-like electroencephalogram (EEG) pattern [1] . At doses that produce comparable levels of unresponsiveness, these three sedatives had different effects on responses to TMS. In awake subjects, TMS produces a complex, multi-peaked field potential (FP) response that lasts for about half a second and has 6 to 8 peaks, i.e. positive to negative voltage deflections. For propofolinduced unresponsiveness, only 2 or 3 peaks remain in the FP response and these peaks are reduced in amplitude. Xenoninduced unresponsiveness is also associated with a reduced number of peaks, but the remaining peaks are higher in amplitude compared to the awake signals. Ketamine, in contrast, produces little effect on either the number of peaks or on their overall amplitude, looking more like awake responses, or responses seen during natural REM dreaming in asleep subjects. The corresponding PCI numbers clearly reflect these differences: propofol = 0.2 to 0.3 and xenon = 0.05 to 0.25; but ketamine had awake-like values = 0.35 to 0.55. Across all subjects (n = 18 in three groups of 6 each), only those rendered unresponsive with ketamine reported dreaming while under the influence of these drugs. Thus, PCI values > 0.35 appear necessary for the brain to support the conscious activity of dreaming. These dreams did not seem to be associated with any experiences during the period when subjects were rendered unresponsive with ketamine, so they were not driven by sensory inputs. Two important points are made by these experiments: firstly, there are multiple, agent-specific mechanisms for rendering brains unresponsive to environmental stimuli, and, secondly, it is possible for at least a rudimentary form of consciousness to be preserved in otherwise non-responsive subjects. Neither of these points are new, but the present experiments demonstrate them particularly nicely, and more importantly, in a quantitative manner.
The fact that sedatives act through agent-specific mechanisms has been known for a long time (see review by Winters et al. 1967 [4] ). But what those mechanisms are remains a mystery. Results from these new TMS experiments help to clarify how different agents can produce unresponsiveness with and without unconsciousness, via different circuit-level mechanisms. Figure 1 provides a schematic depiction of the complex cortical interconnections from which TMS-induced responses are generated, and how it is possible to alter these responses in different ways to produce an unresponsive brain.
Differing Sedative Effects on Cortical Connections
The differential effects produced by propofol, ketamine and xenon on TMSevoked FPs are reminiscent of previously reported unique agent-specific patterns of effects observed on sensory-evoked potentials and for differential effects on spontaneous EEG signals [4] . But how do these differences come about? Research over the last decade has helped to explain some of these differences based on the signaling molecules that each sedative targets. All of these agents appear to act on a mixture of several molecules, including neurotransmitter receptors, ion channels, synaptic release proteins and metabolic enzymes, but the particular degree of effect on each type of molecule differs among agents [5] . For example, xenon has been shown to inhibit a type of glutamate receptor in cortical circuits that mediate excitatory signal transmission (connections), the so-called NMDA receptors [6] . Ketamine also depresses connections via inhibition of NMDA receptors, but additional effects on other molecular targets must also be occurring to account for the differences in circuit-level effects produced by these two sedatives. Propofol, and other anesthetics, also inhibit NMDA receptors, but to a much lesser extent; instead, GABA receptors found at inhibitory synapses appear to be its major molecular target [7] . Propofol enhances circuit level inhibition by prolonging the open time of GABA-gated chloride channels, thus reducing the effectiveness of excitatory connections between cortical regions. Ketamine has also been shown to enhance GABA-mediated inhibition, but to a much lesser degree than propofol. Xenon, in contrast, does not appear to enhance GABA-mediated inhibition. Instead, xenon can enhance circuit inhibition by opening potassium ion channels, similar to effects produced by other volatile anesthetics [8] . Additional molecular targets have also been shown to play a role for these sedatives and new ones will likely be revealed by further investigation [9] . The differential effects seen on cortical connections can easily come about from varying degrees of agent-specific effects on these multiple molecular targets.
Future Directions
It remains to be seen how useful the quantitative measure of PCI will be for characterizing conscious brain states, but it obviously does not provide a good measure for unresponsiveness, since PCI values close to awake measures are seen during ketamine-induced unresponsiveness. This is not unique to PCI measures. Ketamine also produces a more awake-like spontaneous EEG compared to propofol and xenon. Future studies will need to compare analyses of PCI with other functional brain measures such as the patient sedation index (PSI) from SedLine devices (Masimo) or BIS values (Covidien-Medtronic) used to characterize anesthetic depth. PCI will have to be more sensitive and accurate compared to these other measures to justify the extra work and expense of delivering TMS to patients. Researchers should endeavor to directly compare these different measuring systems whenever possible. Unlike the PCI, both BIS and PSI measures are based on frequency domain analyses of spontaneous EEG signals. In supplemental data provided in Figure S2 , Sarasso et al. show using traditional frequency spectrographic analysis of spontaneous EEG, in the same subjects used to test PCI, that all three agents produced elevations in low frequency delta and theta oscillations when subjects became unresponsive. Recent work has shown that spectrographic analysis of EEG signals does not provide the sensitivity needed to reliably distinguish between conscious and unconscious brain states at just threshold doses for sedation [10] , or between natural slow wave sleep and sedation [11] . However, taking a dynamical systems approach to EEG signal analysis (chaos analysis) provided a more sensitive measure that can distinguish between these differing brain states [11] . Ultimately we may need to use both a stimulation (TMS) response measure, spectral and/or chaotic analysis to determine levels of consciousness in unresponsive patients. Transcranial magnetic stimulation (TMS) activates synaptically connected cortical regions (circles) in a time-dependent and spatially distributed manner. Different circuit level mechanisms can account for the different TMS-evoked responses produced by sedation with propofol, ketamine or xenon. In an awake conscious brain, TMS evokes a complex multipeak, long-lasting field potential (FP), because the stimulus spreads via synaptic connections between cortical regions, with further away regions responding in a delayed manner to the stimulus (early to late responses go from dark green to light yellow). Note also the recurrent connections that can give rise to even longer-lasting responses that make up late peaks in FP responses. Propofol produces unresponsiveness by weakening synaptic connections (red arrows), and by breaking connections to some cortical regions (white circles). Xenon also weakens some connections resulting in unresponsive cortical regions, but paradoxically enhances some connections (larger blue arrows) that give rise to large amplitude but less complex FP responses. Ketamine differs from the other two sedatives studied by preserving the complexity of FP responses, even though these responses come about by a different activation pattern than in the awake brain. Enough of the complex interconnections are preserved in the presence of ketamine to allow 'dream consciousness' in an otherwise unresponsive brain.
